Production (Stage)
Addex Therapeutics Ltd
ADXN
$8.40
$0.192.31%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/12/2025
-
TipRanks Financial Blog
5/12/2025
-
Globe Newswire
5/1/2025
-
Ticker Report
4/30/2025
-
GuruFocus
4/30/2025
-
The Fly
4/30/2025
-
Ticker Report
4/30/2025
-
TipRanks Financial Blog
4/30/2025
-
Globe Newswire
4/26/2025
-
GuruFocus
4/26/2025
-
GuruFocus
4/25/2025
-
Seeking Alpha: Transcripts
4/25/2025
-
SeekingAlpha
4/25/2025
-
SeekingAlpha.com: All News
4/25/2025
-
Globe Newswire
4/24/2025
-
Globe Newswire
4/17/2025
-
Ticker Report
4/17/2025
-
GuruFocus
4/17/2025
-
The Fly
4/17/2025
-
TipRanks Financial Blog
4/17/2025
-
Globe Newswire
1/17/2025
-
Ticker Report
1/8/2025
-
Globe Newswire
12/29/2024
-
Ticker Report
12/15/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of September (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
41 22 884 1555
Address
Chemin des Mines, 9
Geneva, 1202
Geneva, 1202
Country
Year Founded
Business Description
Sector
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the...
more